Abstract:Background and objective Excessive osteoclast activity is a major characteristic of pathogenic bone loss in inflammatory bone diseases including periodontitis. However, beyond the knowledge that osteoclasts are differentiated from the monocyte/macrophage lineage and share common ancestry with macrophages and DC, the nature and function of osteoclast precursors are not completely understood. Furthermore, little is known about how osteoclast precursors respond to bacterial infection in vivo. We have previously demonstrated in vitro that the periodontal pathogen Porphyromonas gingivalis (Pg) plays a biphasic role on the receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclast differentiation. In this study, we investigated the in vivo effect of Pg infection on the regulation of osteoclast precursors, using a mouse calvarial infection model. Methods and results C57BL/6 wild-type and the myeloid differentiation factor 88 knockout (MyD88(-/-)) mice were infected with Pg by calvarial injection. Local and systemic bone loss, and the number and function of CD11b(+)c-fms(+) cells from bone marrow and spleen were analyzed. Our results show that Pg infection induces localized inflammatory infiltration and osteoclastogenesis, as well as increased number and osteoclastogenic potential of CD11b(+)c-fms(+) osteoclast precursors in the bone marrow and periphery. We also show that CD11b(+)c-fms(+)RANK(+) and CD11b(+)c-fms(+)RANK(-) are precursors with similar osteoclastogenic and pro-inflammatory potentials. In addition, CD11b(+)c-fms(+) cells exhibit an antigen-specific T-cell immune-suppressive activity, which are increased with Pg infection. Moreover, we demonstrate that MyD88 is involved in the regulation of osteoclast precursors upon Pg infection. Conclusions In this study, we demonstrate an enhanced dual function of osteoclast precursors following calvarial Pg infection. Based on our findings, we propose the following model: Pg infection increases a pool of precursor cells that can be shunted toward osteoclast formation at the infection/inflammation sites, while at the same time dampening host immune responses, which is beneficial for the persistence of infection and maintenance of the characteristic chronic nature of periodontitis. Understanding the nature, function, and regulation of osteoclast precursors will be helpful for identifying therapeutic interventions to aid in the control and prevention of inflammatory bone loss diseases including periodontitis.

GalNAc‐Conjugated siRNA Targeting Complement C3 Inhibits Osteoclast Activation in Periodontitis

C3-targeted Therapy in Periodontal Disease: Moving Closer to the Clinic

CpG Oligodeoxynucleotides Inhibit the Proliferation and Osteoclastic Differentiation of RAW264.7 Cells

CCL2-scavenging Nanodecoy Hydrogel Multi-Step Remodel Monocytes Recruitment and Macrophages Polarization for Periodontitis Treatment

Nanoparticulate cell-free DNA scavenger for treating inflammatory bone loss in periodontitis

Multifunctionalized and Dual‐Crosslinked Hydrogel Promotes Inflammation Resolution and Bone Regeneration via NLRP3 Inhibition in Periodontitis

MiRNA-218 regulates osteoclast differentiation and inflammation response in periodontitis rats through Mmp9.

Lactobacillus rhamnosus inhibits osteoclast differentiation by suppressing the TLR2/NF-κB pathway

The Interaction of CD300lf and Ceramide Reduces the Development of Periodontitis by Inhibiting Osteoclast Differentiation

Using genetics to explore complement C5 as a druggable protein in periodontitis

The Silencing of Cathepsin K Used in Gene Therapy for Periodontal Disease Reveals the Role of Cathepsin K in Chronic Infection and Inflammation.

CRISPR/Cas13d Targeting GZMA in PARs Pathway Regulates the Function of Osteoclasts in Chronic Apical Periodontitis

CCL2 is a key regulator and therapeutic target for periodontitis

Chitooligosaccharide Inhibits RANKL-induced Osteoclastogenesis and Ligation-Induced Periodontitis by Suppressing MAPK/ C-Fos/nfatc1 Signaling.

Stiffness-tuned and ROS-sensitive hydrogel incorporating complement C5a receptor antagonist modulates antibacterial activity of macrophages for periodontitis treatment

Regulatory T Cells Engineered with Polyphenol-Functionalized Immunosuppressant Nanocomplexes for Rebuilding Periodontal Hard Tissue under Inflammation-Challenged Microenvironment

A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis

Genetically engineered cell membrane-coated nanoparticles for antibacterial and immunoregulatory dual-function treatment of ligature-induced periodontitis

Multifunctional sericin-based biomineralized nanoplatforms with immunomodulatory and angio/osteo-genic activity for accelerated bone regeneration in periodontitis

Osteoprotective Role of the <i>Mir338</i> Cluster Ablation during Periodontitis

Enhanced Dual Function of Osteoclast Precursors Following Calvarial Porphyromonas Gingivalis Infection